ALL eukaryotic cells adapt to different environmental and internal stresses to survive. Cells have different signaling mechanisms to elicit specific responses to diverse stresses they encounter. One such mechanism is continuous remodeling of the plasma membrane (PM) in response to different stimuli. Yeast cells remove or downregulate several amino acid, sugar, and metal transporters from the PM through ubiquitin-mediated endocytosis in response to the availability of the specific nutrients in the external media ([@bib34]; [@bib49]; [@bib48]; [@bib55]; [@bib23]; [@bib51]; [@bib38]; [@bib4]; [@bib35]). Upon receiving specific internalization stimuli, these PM proteins are ubiquitinated. This step is accomplished by an E3 ubiquitin ligase, [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) (homolog of the mammalian Nedd4 family ubiquitin ligases) with the help of the PY motif-containing α-arrestin family adapter proteins ([@bib6]; [@bib34]; [@bib65]). The PM proteins modified by ubiquitination are internalized and ultimately delivered to the vacuolar lumen for degradation. Several of the yeast α-arrestins have been shown to act as cytosolic sensors of nutrient levels. These α-arrestins tend to be highly phosphorylated, with altered phosphorylation in response to the presence of the relevant nutrient stimulating their recruitment to the PM, interaction with the corresponding transporter, and binding to [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview).

We previously described a potential pH homeostatic mechanism involving the ubiquitin-mediated endocytic downregulation of the PM H^+^-ATPase ([Pma1](http://www.yeastgenome.org/locus/S000002976/overview)) in response to the inhibition or deletion of organellar vacuolar-H^+^-ATPases (V-ATPases) ([@bib42]; [@bib71]; [@bib67]). V-ATPases are multi-subunit proton pumps, which acidify the lumens of the acidic organelles such as vacuoles/lysosomes, Golgi, and endosomes in all eukaryotic cells. [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is a single-subunit transmembrane proton pump, which pumps protons to the cell exterior and acts as the primary determinant of cytosolic pH. [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in yeast lacking functional V-ATPases requires the α-arrestin family protein [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) and the [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) ubiquitin ligase ([@bib67]). Moreover, we showed that downregulation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) through endocytosis is growth compensatory in yeast lacking functional V-ATPases, as the deletion of [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) or the inhibition of [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) in V-ATPase (*vma*) mutants causes a strong synthetic growth defect ([@bib67]). Interestingly, the PM levels of one of the mammalian cytosolic pH regulators, a Na^+^/H^+^ exchanger (NHE1), are also regulated by endocytosis mediated by an E3-ubiquitin ligase, Nedd4, acting in concert with β-arrestin1 ([@bib66]). This suggests that cross talk between organelle and PM pH regulators is conserved across species.

[Rim8](http://www.yeastgenome.org/locus/S000003013/overview) was previously characterized for its role in the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) signaling pathway, which senses alkaline external pH and generates a transcriptional response ([@bib40]; [@bib50]). High external pH is sensed by a three-protein, pH-sensing complex on the PM comprised of [Rim21](http://www.yeastgenome.org/locus/S000005238/overview), [Rim9](http://www.yeastgenome.org/locus/S000004667/overview), and [Dfg16](http://www.yeastgenome.org/locus/S000005556/overview) ([@bib19]; [@bib40]). The pH signal is transduced from the pH-sensing complex via [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) to the downstream signal-receiving components comprised of endosomal sorting complexes required for transport proteins and a scaffold protein called [Rim20](http://www.yeastgenome.org/locus/S000005801/overview), which docks the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) transcription factor on the endosomal membrane ([@bib78]; [@bib26], [@bib28]; [@bib40]; [@bib50]). These events culminate in the proteolytical cleavage of [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) and its translocation into the nucleus to modulate transcription to achieve adaptation to high external pH ([@bib40]).

Endocytic downregulation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in *vma* mutants was initially surprising, because [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is an essential protein with a very long half-life at the PM and its levels appear to be tightly regulated ([@bib63]; [@bib14]). However, it is well known that [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity is highly regulated post-translationally, particularly in response to glucose availability and intracellular pH ([@bib62]; [@bib20]; [@bib69]; [@bib43]). This regulation is complex and incompletely understood. One regulatory pathway involves a glucose-stimulated phosphorylation of the C-terminal tail of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), which has been attributed to the [Ptk2](http://www.yeastgenome.org/locus/S000003820/overview) kinase and may alter the interaction of the tail with the catalytic domain ([@bib12]; [@bib32]). However, mutations in a number of other kinases and phosphatases alter [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) regulation in response to glucose or cytosolic pH, but their regulatory mechanisms are not understood.

In this study, we sought to identify candidates required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization to further decode signaling events in this pathway. We tested whether components of the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) pathway other than [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) are required for Pma1internalization, and found that [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) plays a distinct role in [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization. We also assessed the involvement of two phosphatases that have been implicated in both signaling through other α-arrestins and regulation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity, the calcium-dependent serine/threonine protein phosphatase calcineurin (CN) and a glucose-dependent serine/threonine protein phosphatase type 1 homolog [Glc7](http://www.yeastgenome.org/locus/S000000935/overview). Both of these phosphatases are essential for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants, and we characterize their genetic and biochemical interactions with the pathway.

Materials and Methods {#s1}
=====================

Yeast strains and media {#s2}
-----------------------

Genotypes of yeast strains used in this study are listed in [Table 1](#t1){ref-type="table"}. Yeast cells were maintained in YEPD (10% yeast extract, 5% peptone, and 2% glucose buffered to pH 5, with 50 mM of potassium succinate and potassium phosphate) or in SD (fully supplemented minimal media) (0.67% yeast nitrogen base, 2% glucose, and all amino acid supplements) ([@bib64]). *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* was constructed as described ([@bib68]). Strain *[snf1](http://www.yeastgenome.org/locus/S000002885/overview)*Δ::*[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* was obtained from Saul Honigberg ([@bib29]). Strain *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^*::*kanMX* was obtained from Charlie Boone, University of Toronto ([@bib33]). Strain BY4741 *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP*::*[HIS3](http://www.yeastgenome.org/locus/S000005728/overview)* was purchased from Invitrogen (Carlsbad, CA) and the *[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)* gene was deleted in a single-step gene replacement to create strain *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*[URA3](http://www.yeastgenome.org/locus/S000000747/overview)[crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP* by lithium acetate transformation, as described previously ([@bib18]), using a PCR product amplified from the genomic DNA of a *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* strain using primers [VMA2](http://www.yeastgenome.org/locus/S000000331/overview)(−840) and VMA2-c4 ([Table 2](#t2){ref-type="table"}).

###### Yeast strains

  Strain                               Genotype                                                                                              Source
  ------------------------------------ ----------------------------------------------------------------------------------------------------- ---------------------
  BY4741                               *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0*                                                       Open Biosystems
  BY4742                               *MAT*α his3Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0*                                                            Open Biosystems
  *BY4741 vma2*Δ                       *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 vma2*Δ::*KanMx*                                        Open Biosystems
  *Y3656 vma2*Δ                        *MAT*α can1Δ:: *MFA1pr-his3-MF*α1pr-Leu2 ura3Δ*0 leu2*Δ*0 his3*Δ*1 met15*Δ*0 lys2*Δ*0 vma2*Δ::*Nat*   Kane laboratory
  *BY4742 cnb1*Δ                       *MAT*α his3Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0 cnb1*Δ::*Nat*                                               Open Biosystems
  *cnb1*Δ *vma2*Δ                      Spore from cross between *BY4741 vma2*Δ and *BY4742 cnb1*Δ                                            This study
  *BY4741 reg1*Δ                       *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 reg1*Δ::*KanMx*                                        Open Biosystems
  *BY 4741glc7-12^ts^*                 *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 glc7-12^ts^*:: *KanMx*                                 From Charlie Boone
  *glc7-12^ts^ vma2*Δ                  Spore from cross between *Y3656 vma2*Δ and *BY 4741glc7-12^ts^*                                       This study
  *BY4741 rim20*Δ                      *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 rim20*Δ::*KanMx*                                       Open Biosystems
  *BY4741 rim21*Δ                      *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 rim21*Δ::*KanMx*                                       Open Biosystems
  *vma2*Δ *rim20*Δ                     Spore from cross between *Y3656 vma2*Δ and *BY 4741 rim20*Δ                                           This study
  *vma2*Δ *rim21*Δ                     Spore from cross between *Y3656 vma2*Δ and *BY 4741 rim21*Δ                                           This study
  *BY4741 rim8*Δ                       *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 rim8*Δ::*KanMx*                                        Open Biosystems
  *vma2*Δ *rim8*Δ                      Spore from cross between *Y3656 vma2*Δ and *BY 4741 rim8*Δ                                            Kane laboratory
  *BY4741 ptk2*Δ::*hygB*               *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 ptk2*Δ::*HygB*                                         This study
  *BY4741 ptk2*Δ::*kan*                *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 ptk2*Δ::*kanMx*                                        Open Biosystems
  *vma2*Δ *ptk2*Δ *glc7-12^ts^*        Spore from cross between *glc7-12^ts^ vma2*Δ and *BY4741 ptk2*Δ::*hygB*                               Open Biosystems
  BY4741 *crz1*Δ                       *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 crz1*Δ::*kan*                                          Open Biosystems
  *vma2*Δ *crz1*Δ                      Spore from cross between *Y3656 vma2*Δ and *BY 4741 crz1*Δ                                            This study
  *SH snf1*Δ                           W303 *snf1*Δ::*URA3*                                                                                  From Saul Honigberg
  *BY 4741 crz1-GFP*                   *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 crz1-GFP*                                              Invitrogen
  *BY 4741 crz1-GFP vma2*Δ             *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 vma2*Δ::*URA3 crz1-GFP*                                This study
  *BY4741 Pma1-007*::*KanMx*           *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 Pma1-007*::*KanMx*                                     Open Biosystems
  *BY4741 Pma1-007*::*HygB*            *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 Pma1-007*::*HygB*                                      Kane laboratory
  BY4741 *Rim8 P506A*-3HA              *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 Rim8 P506A-3HA-KanMx*                                  This study
  *vma2*Δ *Rim8 P506A*-3HA             Spore from cross between *Y3656 vma2*Δ*/* pRS316 vma2-URA3 and BY4741 *Rim8 P506A*-3HA                This study
  *vma2*Δ *Pma1-007*                   Spore from cross between *vma2*Δ *Rim8 P506A*-3HA/pRS316 vma2-URA3 and *BY4741 Pma1-007*::*HygB*      This study
  *Pma1-007 Rim8 P506A*-3HA            Spore from cross between *vma2*Δ *Rim8 P506A*-3HA/pRS316 vma2-URA3 and *BY4741 Pma1-007*::*HygB*      This study
  *vma2*Δ *Rim8P506A*-3HA *Pma1-007*   Spore from cross between *vma2*Δ *Rim8 P506A*-3HA/pRS316 vma2-URA3 and *BY4741 Pma1-007*::*HygB*      This study
  BY4741 *Rim8*-3HA::*KanMx*           *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 Rim8*-3HA::*KanMx*                                     Kane laboratory
  *BY4741 rcy1*Δ                       *MAT***a** his3Δ*1 leu2*Δ*0 met15*Δ*0 ura3*Δ*0 rcy1*Δ::*KanMx*                                        Open Biosystems

###### Primers used in this study

  Primer name       Sequence (5′--3′)
  ----------------- -----------------------------------------------------------------------------------------------------------
  VMA2(−840)        `GAATCGGCTAGAGATTACAAGCTCA`
  VMA2-c4           `GATGTTCTTCGAGACCGGGTTGG`
  Rim8:451URAfor    `TTC AAA GAT ATG GTA AAT GTG GAA AAG CTA AAG AGA CTG AGG AAT GTA ACT GGT TAC TGA GAG TGC ACC ACGCT`
  Rim8:end URArev   `ATA GTC ATC ACA AGG GGG AGG ATC GCT TTC TAA CTG TTG TAG TCT TTT TTG TTC AAG CAG TTT TTT AGT TTG CTG GCC`
  P506A.For         `TTTATCATTTGGCGAATACTTTGCAACTGGAACATCGTCACTATCATA`
  P506A.Rev         `GTCAGTGTACCGTCGGAAGACAGACAAGAACTTGAACAAAAAAGAC`
  Rim8-F2           `TTAATTAACCCGGGGATCCGATAGTCATCACAAGGGGGAGGATC`
  Rim8-R1           `GTTTAAACGAGCTCGAATTCAAAGTGCAGGTAACAAGTCATATACTCG`
  Rim8 553          `GAAGCAAGATGCGAACGTGAG`

To generate double and triple mutants, congenic haploid strains harboring single gene deletions were crossed, and the resulting diploids were sporulated for ∼3--5 days as described ([@bib31]). Tetrads were dissected, and the genotypes of the individual spores were confirmed via the selectable markers. The double mutants *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*Δ, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*Δ, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *rimP506A-3HA*, and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* were created by sporulation and tetrad dissection after crossing strains BY4741 *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*kanMx* and BY4742 *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ::*nat*, *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* and BY4741 *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*::*kanMx*, *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* and BY4741 *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*Δ::kanMx, *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* and BY4741*[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ::*kanMx*, *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* and BY4741*[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ::*kanMx*, *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat* and BY4741*[rim8](http://www.yeastgenome.org/locus/S000003013/overview) P506A-3HA*::*kanMx*, and *Y3656 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ::*nat and glc712^ts^*::*kanMx*, respectively. Triple mutant *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*Δ was created by tetrad dissection by crossing strains *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* and *BY4741ptk2*Δ::*hygB*. Double mutants *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* and *rimP506A-3HA [pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007*, and triple mutant *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *rimP506A-3HA [pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007*, were obtained by tetrad dissection as described above by crossing strains *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *rimP506A-3HA*, carrying the *[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)* gene on plasmid pRS316, and *BY4741 [pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007*::*hygB*. Growth of spores of different genotypes were compared by growing liquid cultures of each strain to log phase, then spotting 10-fold serial dilutions onto the relevant plates. The plates were incubated at the appropriate temperature for at least 3 days.

To make the BY4741*[rim8](http://www.yeastgenome.org/locus/S000003013/overview)* P506A-3HA::*kanMx* mutant, we first PCR amplified the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* gene from the pRS316 plasmid, flanked by ∼50-bp sequences upstream and downstream of [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) amino acids 451--539, using primers [Rim8](http://www.yeastgenome.org/locus/S000003013/overview):451URAFor and [Rim8](http://www.yeastgenome.org/locus/S000003013/overview):endURARev ([Table 2](#t2){ref-type="table"}). This PCR product was introduced into the BY4741 [Rim8](http://www.yeastgenome.org/locus/S000003013/overview)-3HA-kanMx strain (see below), replacing the sequence for amino acids 451--539 with *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* to construct the BY4741 Rim8450-[URA3](http://www.yeastgenome.org/locus/S000000747/overview)-Rim8STOP-3HA::kanMx strain. The [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) P506A mutation was first introduced into a plasmid-borne copy of *[RIM8](http://www.yeastgenome.org/locus/S000003013/overview)* using primers P506AFor and P506ARev ([Table 2](#t2){ref-type="table"}) with a quick-change site-directed mutagenesis kit (Stratagene, La Jolla, CA) and sequenced. A fragment containing the [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) P506A mutation was then PCR amplified using primers Rim8553 and Rim8R1 ([Table 2](#t2){ref-type="table"}) and transformed into BY4741 Rim8450-[URA3](http://www.yeastgenome.org/locus/S000000747/overview)-Rim8STOP-3HA::kanMx. Transformants were plated on plates containing 5-fluoroorotic acid (5-FOA) to select for replacement of *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)*. Incorporation of the [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) P506A mutation was confirmed by sequencing.

To tag [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) at its C-terminus with a 3HA (hemagglutinin) tag, the 3HA-kanMx6 cassette from plasmid pFA6a-3HA-kanMX6 ([@bib36]) was amplified using primers [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) F2 and [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) R1 ([Table 2](#t2){ref-type="table"}). The cassette was introduced into the BY4741 wild-type strain, transformants resistant to G418 (kan) were selected, and in-frame incorporation of the tag was confirmed by sequencing.

Fluorescence microscopy {#s3}
-----------------------

We used indirect immunofluorescence to observe [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization. Cells were grown to log phase and then fixed and permeabilized as described ([@bib58]). The fixed and permeabilized cells were washed with 1% SDS for 1 min, then immobilized on glass slides coated with 1 mg/ml polylysine ([@bib58]) and incubated overnight at room temperature with a 1:200 dilution of anti-[Pma1](http://www.yeastgenome.org/locus/S000002976/overview) antibody (mouse monoclonal 40B7; Novus Biologicals). The next day, cells were gently washed with ice cold PBS-BSA (5 mg/ml bovine serum albumin in phosphate-buffered saline) and incubated for 1 hr at room temperature with a 1:300 dilution of Alexa-fluor 488-conjugated goat anti-mouse secondary antibody from Invitrogen ([@bib42]; [@bib67]). The cells were washed finally with PBS-BSA and layered with mounting media before covering with a cover slip. Cells were visualized using differential interference contrast, and fluorescein isothiocyanate filters on a Zeiss (\[Carl Zeiss\], Thornwood, NY) Imager Z1 fluorescence microscope ([@bib67]) attached to a Hamamatsu CCD camera. Images were obtained using Zeiss Axiovision software.

To observe the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization in *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* and *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells, cells were initially grown to log phase at the permissive 25°, followed by pelleting and resuspension of ∼10 OD~600~ of cells in YPD pH 5 prewarmed to the nonpermissive 37°. The cells were incubated at the nonpermissive temperature of 37° for 2 hr before fixation and visualization. To inhibit CN in a *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ mutant, cells were grown to midlog phase (0.6 OD~600~) then diluted to 0.2 OD~600~ and divided into equal volumes. The diluted *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were treated for 2, 4, and 6 hr with 10 μg/ml of the CN-specific inhibitor FK-506 (Tacrolimus) purchased from AG Scientific. The DMSO solvent for the FK-506 was applied in parallel as a vehicle treatment. At each time point, DMSO and the FK-506-treated cells were collected, fixed, and permeabilized for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) indirect immunofluorescence. To localize [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) after acute inhibition of V-ATPases, we treated the wild-type cells and the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* cells grown to the midlog phase with 2 μM of the V-ATPase inhibitor concanamycin A for 30 min, followed by fixation and visualization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) indirect immunofluorescence as described above.

Wild-type and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells expressing [Crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP were grown to midlog phase in minimal media. To mark the cell nucleus, cells were incubated with 2.5 mg/ml of DAPI (4',6-diamidino-2-phenylindole, dihydrochloride) stain at 30° for 30 min. Then cells were washed once with minimal media and resuspended in minimal media. [Crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP was visualized with a GFP filter set and DNA was visualized with a DAPI filter set.

FM 4-64 uptake assay {#s4}
--------------------

As a measure of bulk endocytosis, we observed uptake of the lipophilic dye N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino) phenyl) hexatrienyl pyridinium dibromide (FM 4-64) (Molecular Probes, Eugene, OR/Invitrogen). To assess the effect of [PP1](http://www.yeastgenome.org/locus/S000000935/overview) inhibition, wild-type, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ, *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^*, and *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were allowed to grow to midlog phase in YEPD pH 5. For each strain, three separate aliquots of cell suspension (equivalent to 1 OD~600~ unit of cells) were pelleted and resuspended in ice-cold YEPD pH 5 containing 20 μM FM 4-64. To initially label only the PMs, cells were pulse labeled on ice with continuous shaking for 20 min ([@bib74]), washed with ice-cold fully supplemented minimal media to reduce background fluorescence, and imaged using a Texas Red filter. The remaining two tubes from each mutant were washed twice with YEPD pH 5 prewarmed to either 25° (permissive for *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^*) or 37° (nonpermissive for *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^*). After pelleting to remove excess dye, the pellets were resuspended in YEPD pH 5 and chased for 2 hr either at 25 or 37°, then washed with fully supplemented minimal media and imaged as above. To check the effects of CN inhibition, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were grown to midlog phase and distributed across seven tubes (cell volumes equivalent to 1 OD~600~ units in each). Pelleted cells were resuspended in 1 ml ice-cold YEPD pH 5 containing FM 4-64 as described above. After a 20 min pulse labeling, one tube of cells was washed and imaged as described above, and the other tubes were washed twice with room temperature YEPD pH 5 and resuspended in 1 ml of YEPD pH 5. FK-506 was added (final concentration 10 μg/ml) to three tubes and DMSO was added to the other three. Samples were chased at 30° for 2, 4, and 6 hr, then washed and imaged as described above.

Quantification and statistical analysis of the Pma1 indirect immunofluorescence {#s5}
-------------------------------------------------------------------------------

PM fluorescence of the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in all the experiments was quantified using National Institutes of Health (NIH) Image J version 2.0.0-rc-54/1.51f as described ([@bib67]). We adapted the cell fluorescence quantification methods described ([@bib17]; [@bib45]) with slight modifications. An outline was drawn using one of the Image J shape tools around the outer edge of the yeast cell and area, integrated density, and mean gray value were measured. Then using the same shape, similar measurements were taken in the background adjacent to the cell. The "Total Cell Fluorescence" (TCF) was calculated using the formula "Integrated density -- (area × mean gray value of the background)." Next, using a shape tool, an outline was drawn inside the cell just below the PM, again measuring the same parameters as above, and "Fluorescence Internal to the PM" (FI) of the cell was calculated using the same formula. The "PM Fluorescence Intensity" (PMFI) of the cell was calculated by subtracting the FI from the TCF. Finally, the PMFI of the cell was divided by the integrated density of the cell to get "Normalized PM fluorescence intensity" (NPMFI). In every biological replicate, 52 cells from at least six different fields were quantified for each cell type. All the well-focused cells in a field were measured. The NPMFI between different cell types in an experiment were compared using bar charts, and a paired Student's *t*-test was performed using GraphPad to determine if the difference between mean NPMFI among different cell types was significant. *P*-value ≤ 0.05 was considered significant.

Immunoprecipitation and immunoblotting {#s6}
--------------------------------------

To test the effect of inhibition of [PP1](http://www.yeastgenome.org/locus/S000000935/overview) on the ubiquitination of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* and the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were initially grown to midlog phase (0.6 OD~600~) in YPD pH 5 at 25°. Cell suspension equivalent to 60 OD~600~ units was pelleted and resuspended in medium prewarmed to 37° for 2 hr. Wild-type and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were used as negative and positive controls, respectively, and a *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* suspension maintained at 25° was also included. Equal cell numbers (determined from OD~600~) were pelleted and frozen at −80° until immunoprecipitation. To test the effect of CN on [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination, midlog (0.6 OD~600~) phase cultures were diluted to 0.2 OD~600~ and treated in separate flasks with either DMSO or FK-506 (10 μg/ml) for 2, 4, and 6 hr at 30°. Wild-type cells and the untreated *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells were used as negative and positive controls, respectively, and all samples were pelleted and frozen as described above.

Immunoprecipitations were performed as described in [@bib67], with some modifications. The frozen cell pellets were resuspended in 300 μl ice-cold lysis buffer (50 mM Tris-HCL pH 7.5, 100 mM NaCl, and 0.1 mM EDTA) with protease, phosphatase, and deubiquitinase inhibitors (1 mM PMSF, 1 μg/ml leupeptin, 5 μg/ml aprotinin, 2 μg/ml pepstatin, 10 mM NaF, 1 mM Na~3~VO~4~, and 25 mM N-ethylmaleimide). The cells were lysed by agitation with an equal volume of acid-washed glass beads (300 μl) at 4°. Next, 1% Triton-X 100, 1% sodium deoxycholate, and 0.1% SDS were added to the lysate, and the mixture was incubated on ice for 30 min. Lysates were then diluted with 1 ml of ice-cold lysis buffer (with all the inhibitors) to decrease the concentration of detergent, followed by centrifugation for 5 min to remove the insoluble material. The supernatant was incubated with 50 μl Protein A Sepharose beads for 20 min on ice to preabsorb proteins binding nonspecifically \[Protein A Sepharose CL-4B powder (GE Healthcare) (17 mg/sample) was swollen overnight in PBS-BSA and washed in PBS-BSA for three times before use\]. After centrifugation, the supernatant was incubated overnight at 4° with 7 μl of anti-mouse monoclonal antibody against [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) (40B7) purchased from Novus Biologicals. The next day, 60 μl of 50% (v/v) suspension of protein A Sepharose CL-4B was added to the samples and incubated at 4° for 2 hr. Then the immunoprecipitate was washed three times with the ice-cold lysis buffer and solubilized in cracking buffer (50 mM Tris-HCL, pH 6.8, 8 M urea, 5% SDS, and 5% β-mercaptoethanol) at 55° for 10 min. The immunoprecipitates were analyzed by electrophoresis using an 8% SDS-polyacrylamide gel and western blotting. Identical volumes from all the samples were loaded into separate wells of the gel. Total [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in each sample was compared by probing with 1:5000 of anti-rabbit polyclonal Ab against [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) (a generous gift from Amy Chang), and the ubiquitinated portion of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) was visualized and compared by probing with 1:250 of anti-mouse (P4D1) monoclonal IgG against ubiquitin (Santa Cruz Biotechnology). Secondary antibodies conjugated with alkaline phosphatase (Promega, Madison, WI) were used to visualize protein bands using an AP conjugate substrate kit (Bio-Rad, Hercules, CA). Three independent experiments were performed and the band intensities were quantified using NIH Image J version 2.0.0-rc-54/1.51f as described in [@bib67].

Phosphorylated and total [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) were visualized in the presence and absence of glucose, as described in [@bib54] with some modifications. Whole-cell lysates were prepared as described in [@bib54] for western blotting. To detect phosphorylated [Snf1](http://www.yeastgenome.org/locus/S000002885/overview), blots were probed with a 1:1000 dilution of phospho-AMPKα (Thr172) antibody (Cell Signaling Technology) in TBST (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, and 0.1% Tween 20) incubated overnight at 4°. Total endogenous [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) was detected by probing with monoclonal anti-poly-histidine antibody (H1029) (Sigma \[Sigma Chemical\], St. Louis, MO) at a concentration of 1:3000 in 1% milk incubated overnight at 4°. Protein was detected and quantified as described ([@bib67]).

Data availability {#s7}
-----------------

All reagents and supporting data are available upon request.

Results {#s8}
=======

Pma1 internalization in V-ATPase mutants is independent of the Rim101 pathway {#s9}
-----------------------------------------------------------------------------

[Rim8](http://www.yeastgenome.org/locus/S000003013/overview) is a required component of the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) pathway, so we tested whether other essential components of the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) signaling pathway are required for the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway. We crossed deletion mutants of the upstream pH sensor component [Rim21](http://www.yeastgenome.org/locus/S000005238/overview), which has been shown to interact with [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) ([@bib28]) or the downstream scaffold protein [Rim20](http://www.yeastgenome.org/locus/S000005801/overview), with a *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutant and obtained double-mutant strains by tetrad dissection. Loss of proteins required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization further compromise the growth of yeast *vma* mutants ([@bib67]), so we compared the growth of the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ and the *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutants to that of wild-type cells and the three single mutants using a dilution growth assay ([Figure 1A](#fig1){ref-type="fig"}). The *vma* mutants have a distinctive growth phenotype characterized by very poor growth at elevated pH (pH 7.5) and optimal growth at pH 5. The *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ and *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutants grew similarly to the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells. In contrast, the *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*∆*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ double mutant grows extremely poorly, even at pH 5, consistent with previous results ([@bib67]).

![The internalization of Pma1 in the yeast lacking functional V-ATPase is independent of the components required for the alkaline pH-sensing Rim101 signaling pathway. (A) Dilution growth assay comparing the growth of *rim20*Δ*vma2*Δ, *rim21*Δ*vma2*Δ, and *rim8*Δ*vma2*Δ double mutants with their corresponding single mutants and wild-type (wt) cells. The upstream pH sensor component Rim21 and the downstream scaffold protein rim20 are the required components for Rim101 signaling during external alkaline pH stress, and α-arrestin Rim8 transduces the signal between pH sensor and receiving complexes. We made the *rim20*Δ*vma2*Δ, *rim21*Δ*vma2*Δ, and *rim8*Δ*vma2*Δ double mutants as described in the *Materials and Methods* using tetrad dissection. (B) Anti-Pma1 indirect immunofluorescent image showing the localization of Pma1 in *rim20*Δ*vma2*Δ, *rim21*Δ*vma2*Δ, and *rim8*Δ*vma2*Δ double mutants, their corresponding single mutants, and wt cells. A representative of three independent experiments is shown. (C) Bar graph comparing the plasma membrane Pma1 fluorescence intensity as a fraction of total cell fluorescence intensity (arbitrary units) in different rim101 pathway and *vma* double mutants. Pma1 fluorescence intensity quantified for 52 cells from each mutant as described in the *Materials and Methods*. The *P*-value ≤ 0.05 is considered significant. In the bar graph, \* *P* \< 0.05 and \*\*\* *P* \< 0.0005. *P* \> 0.05 is considered nonsignificant and nonsignificant differences are not indicated in the bar graph. The error bars indicate ± SEM.](655fig1){#fig1}

Next, we tested whether the *vma* mutants require [Rim21](http://www.yeastgenome.org/locus/S000005238/overview) and [Rim20](http://www.yeastgenome.org/locus/S000005801/overview) for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization. Using anti-[Pma1](http://www.yeastgenome.org/locus/S000002976/overview) indirect immunofluorescence in the fixed cells, we localized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ and *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutants and their corresponding single mutants *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ and *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ ([Figure 1B](#fig1){ref-type="fig"}). As expected, the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ and *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ single mutants retained [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) on the PM, similarly to the wild-type cells, whereas the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ and *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutants internalized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) similarly to the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells. Quantification of the PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) fluorescence intensity in these mutants ([Figure 1C](#fig1){ref-type="fig"}) showed that the *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*Δ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutant had slightly higher [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) levels at the PM compared to the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ mutant. However, in contrast to *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*∆*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆, neither the *[rim20](http://www.yeastgenome.org/locus/S000005801/overview)*∆*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ nor the *[rim21](http://www.yeastgenome.org/locus/S000005238/overview)*∆*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ double mutant had significantly different levels of PM fluorescence from the single *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutant ([Figure 1, B and C](#fig1){ref-type="fig"}). These results show that [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) pathway components [Rim21](http://www.yeastgenome.org/locus/S000005238/overview) and [Rim20](http://www.yeastgenome.org/locus/S000005801/overview) are not essential for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants, and suggest that the [Rim101](http://www.yeastgenome.org/locus/S000001019/overview) pathway is not required. Although the α-arrestin [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) is a common component in both the pathways, it appears to perform distinct and independent functions depending on the signal it receives.

Yeast lacking V-ATPase function require PP1 for growth and endocytic downregulation of Pma1 {#s10}
-------------------------------------------------------------------------------------------

The activity of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is post-translationally regulated by phosphorylation and dephosphorylation in response to glucose availability ([@bib11]; [@bib13]; [@bib32]; [@bib43]). The [Reg1](http://www.yeastgenome.org/locus/S000002435/overview) protein is one of several regulatory subunits of a highly conserved, type 1 serine/threonine protein phosphatase, [PP1](http://www.yeastgenome.org/locus/S000000935/overview), which directs the activity of a single catalytic subunit encoded by yeast *[GLC7](http://www.yeastgenome.org/locus/S000000935/overview)* ([@bib73]; [@bib61]). The [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) complex is believed to reduce [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity during glucose starvation by dephosphorylating Ser 899 on the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) C-terminus ([@bib76]; [@bib43]), and *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*Δ cells have higher [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity even during glucose starvation ([@bib80]). Furthermore, [Reg1](http://www.yeastgenome.org/locus/S000002435/overview) interacts directly with the α-arrestin [Rod1](http://www.yeastgenome.org/locus/S000005544/overview)/[Art4](http://www.yeastgenome.org/locus/S000005544/overview) and may promote [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview)-dependent, ubiquitin-mediated endocytosis of the PM lactate transporter [Jen1](http://www.yeastgenome.org/locus/S000001700/overview) ([@bib5]). Considering the role of [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) in both the regulation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity and the endocytosis of other PM transporters, we hypothesized that [PP1](http://www.yeastgenome.org/locus/S000000935/overview) could be involved in [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis as well.

To test this hypothesis, we first attempted to make a *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutant through tetrad dissection. However, we obtained no viable double-mutant spores, as shown by the five tetrads in [Figure 2A](#fig2){ref-type="fig"}, indicating that the two mutations may be synthetically lethal. The [PP1](http://www.yeastgenome.org/locus/S000000935/overview) catalytic subunit [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) is an essential protein in yeast, so we utilized a temperature-sensitive mutant *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* ([@bib39]) and generated *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutants by tetrad dissection at the permissive temperature of 25°. [Figure 2B](#fig2){ref-type="fig"} shows that at the permissive temperature, the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutants grow similarly to the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells. However, at the nonpermissive temperature of 37°, the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* mutants grew very poorly even at pH 5, corroborating the synthetic lethal phenotype of the *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ mutant. This negative synthetic growth phenotype suggested that [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) could be a candidate in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway. Surprisingly, the temperature sensitivity of the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* single-mutant spores is suppressed at pH 5. We previously observed that the temperature sensitivity of the *[rsp5](http://www.yeastgenome.org/locus/S000000927/overview)-1* single mutant is also suppressed at pH 5, while the *[rsp5](http://www.yeastgenome.org/locus/S000000927/overview)-1vma2*∆ mutant grew very poorly ([@bib67]).

![Protein phosphatase type 1 (PP1) is required for the growth of the yeast lacking functional V-ATPases and is required for the internalization of Pma1. (A) The tetrads obtained by crossing a PP1 regulatory subunit mutant, BY4741 *reg1*Δ::*kan*, with *vma* mutant y3536*vma2*Δ::*nat* cells. (B) Dilution growth assay comparing the growth of a *glc7-12^ts^ vma2*Δ double mutant (two double mutants from two different tetrads are shown) with the corresponding *glc7-12^ts^* single mutant (two single mutants from two different tetrads are shown), *vma2*Δ cells, and wild-type (wt) cells at permissive temperature of 25° to that of at the nonpermissive temperature of 37°. The double mutant was obtained by tetrad dissection at 25° by crossing a temperature-sensitive PP1 catalytic subunit mutant, *glc7-12^ts^*:: *kan*, with a *vma* mutant, y3536 *vma2*Δ::*nat*. The *vma* phenotype is verified by checking the growth at YPD pH 7.5 as the *vma* mutant phenotype is conditionally lethal at higher pH. (C) Anti-Pma1 indirect immunofluorescence (see *Materials and Methods*) image of fixed cells comparing the localization of Pma1 in the *glc7-12^ts^vma2*Δ double mutant with the corresponding *glc7-12^ts^* single mutant, *vma2*Δ cells, and the wt cells. The *glc7-12^ts^vma2*Δ double-mutant cells and the glc7-12^ts^ single-mutant cells were initially grown to the log phase in YPD pH 5 at the permissive temperature of 25°; then, to inhibit the PP1 catalytic subunit Glc7, these mutants were shifted to the nonpermissive temperature of 37° for 2 hr. A representative of three independent experiments is shown. (D) Bar graph showing the plasma membrane (PM) Pma1 fluorescence intensity as a fraction of total cell fluorescence intensity (arbitrary units) in different cells in (C). From each strain, 52 cells were quantified for the fluorescent intensity of Pma1 at the PM as a measure of the amount of Pma1 retaining at the PM, as described in the *Materials and Methods*. The *P*-value ≤ 0.05 is considered significant. In the bar graph, \* *P* \< 0.05 and \*\*\* *P* \< 0.0005. *P* \> 0.05 is considered nonsignificant and nonsignificant differences are not indicated in the bar graph. The error bars indicate ± SEM. (E) Micrograph showing the uptake of FM 4-64 dye in wt, *vma2*Δ, *glc7-12^ts^*, and *vma2*Δ *glc7-12^ts^* cells. Cells were initially labeled on ice to mark only the PMs and immediately imaged using a Texas Red filter. Later, cells were chased for 2 hr at either 25 or 37°, as described in the *Materials and Methods*, and imaged using Texas a Red filter to monitor the uptake of FM 4-64 from the PM to the vacuole.](655fig2){#fig2}

We examined [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization in the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* single and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant at both temperatures ([Figure 2C](#fig2){ref-type="fig"}). The *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* mutant maintains wild-type levels of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM at both temperatures ([Figure 2D](#fig2){ref-type="fig"}). At 25°, internalization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant was similar to that in the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells. Remarkably, after a 2 hr shift to 37°, the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* mutant retained wild-type levels of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM, unlike *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells. This result shows that loss of [PP1](http://www.yeastgenome.org/locus/S000000935/overview) activity in *vma* mutants inhibits [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytic downregulation. However, the inhibitory effect of [PP1](http://www.yeastgenome.org/locus/S000000935/overview) on the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis in *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells could be due to a more general effect of [PP1](http://www.yeastgenome.org/locus/S000000935/overview) inhibiting bulk endocytosis from the PM. To check this, we assayed wild-type cells and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ, *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* mutants for the uptake of a bulk endocytosis marker, a lipophilic dye, FM 4-64. Uptake of FM 4-64 from the PM and its delivery to the vacuole is dependent on endocytosis, and it has been used as a vacuolar marker ([@bib74]). [Figure 2E](#fig2){ref-type="fig"} shows that on ice, FM 4-64 labeled only PMs in all the cell types. However, after chasing for 2 hr at either the permissive temperature of 25° or the nonpermissive 37°, the FM 4-64 internalized and labeled vacuolar membranes in all the cell types shown. This result shows that [PP1](http://www.yeastgenome.org/locus/S000000935/overview)'s effect on [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization is not due to an overall inhibition of endocytosis. Instead, these results indicate a specific requirement for [PP1](http://www.yeastgenome.org/locus/S000000935/overview) in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway in *vma* mutants.

Serine 899 (S899) in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) cytosolic C-terminus was previously identified as the target of [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-mediated dephosphorylation under glucose starvation ([@bib43]). We hypothesized that if [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-mediated dephosphorylation of S899 of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is critical for its endocytic downregulation, we should able to rescue the poor growth of the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant at the nonpermissive temperature by deleting the kinase that phosphorylates [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) S899. [Ptk2](http://www.yeastgenome.org/locus/S000003820/overview) kinase was recently shown to be solely responsible for S899 phosphorylation ([@bib43]), so we constructed a *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆*[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*∆ triple mutant. If dephosphorylation of S899 were required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis, we expected that the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ*[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*Δ triple mutant would grow better than the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant at the nonpermissive temperature. However, the dilution growth assay showed that there was no significant growth enhancement of the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*Δ triple mutant relative to the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant at 37° (Supplemental Material, [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.117.300594/-/DC1/FigureS1.tiff)). This result argues that the phosphorylation state of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) S899 is not a critical determinant of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis, but that [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) may target some other site on [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) or another protein in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway.

The [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) complex has been associated with glucose signaling and plays a significant role in glucose repression ([@bib73]; [@bib61]). During glucose starvation, the yeast homolog of AMP-activated protein kinase, [Snf1](http://www.yeastgenome.org/locus/S000002885/overview), is activated by phosphorylation and modulates transcription to support the use of alternate carbon sources ([@bib44]). Upon glucose readdition to glucose-starved cells, the [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) complex dephosphorylates [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) and inactivates it ([@bib61]). *vma* mutants are subject to multiple stresses, so we asked whether [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) is activated in *vma* mutants even without glucose starvation; if so, the [Reg1](http://www.yeastgenome.org/locus/S000002435/overview) requirement in *vma* mutants might be directed toward limiting [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) activity. We observed the activation state of [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) in wild-type, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ, *[snf1](http://www.yeastgenome.org/locus/S000002885/overview)*Δ, and *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*Δ whole-cell lysates by probing western blots with antibodies recognizing total and phosphorylated [Snf1](http://www.yeastgenome.org/locus/S000002885/overview). The western blot shown in [Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.117.300594/-/DC1/FigureS2.tiff) shows that wild-type and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells have comparable levels of total [Snf1](http://www.yeastgenome.org/locus/S000002885/overview), a protein that is phosphorylated to similar levels in the absence of glucose. In contrast, *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*Δ cells have higher levels of phosphorylated [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) even in the presence of glucose and levels increase further under glucose starvation, characteristic of [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) hyperactivation. Thus, [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) is not hyperactive in *vma* mutants under normal growth conditions and is unlikely to be the critical [Reg1](http://www.yeastgenome.org/locus/S000002435/overview)/[Glc7](http://www.yeastgenome.org/locus/S000000935/overview) target in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway. Instead, [Reg1](http://www.yeastgenome.org/locus/S000002435/overview) may direct [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) to another critical component.

PP1 acts upstream of Pma1 ubiquitination in the endocytic downregulation pathway {#s11}
--------------------------------------------------------------------------------

Ubiquitination of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is a critical step in its internalization ([@bib67]), so we examined whether [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination is impaired in a [PP1](http://www.yeastgenome.org/locus/S000000935/overview) mutant. We immunoprecipitated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) from wild-type and mutant cells and probed the immunoprecipitated protein with anti-[Pma1](http://www.yeastgenome.org/locus/S000002976/overview) antibody to assess total [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) levels, and with anti-ubiquitin antibody to assess the extent of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination ([Figure 3](#fig3){ref-type="fig"}). We previously demonstrated that wild-type cells contain little, if any, ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), but that *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutants contain both lower levels of total [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) and increased [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination ([@bib67]). We did not detect any ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in wild-type cells or the *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* cells at either temperature, consistent with the PM localization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) (the anti-[Pma1](http://www.yeastgenome.org/locus/S000002976/overview) antibody frequently shows multiple bands on immunoblots, as shown in [Figure 3](#fig3){ref-type="fig"}, but this does not necessarily indicate ubiquitination.) In the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells, total levels of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) were somewhat lower than in wild-type cells, and higher levels of ubiquitination were present, as expected. At 25°, the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12^ts^* double mutant shows increased [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination like in the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ strain, and the ratio of the ubiquitin signal to the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) signal resembled that of the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ strain. However, ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is undetectable when the double mutant is shifted to 37° for 2 hr. This result demonstrates that ubiquitination of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in *vma* mutants requires [PP1](http://www.yeastgenome.org/locus/S000000935/overview), and places [PP1](http://www.yeastgenome.org/locus/S000000935/overview) activity upstream of the critical step of [Rim8](http://www.yeastgenome.org/locus/S000003013/overview)- and [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview)-dependent ubiquitination of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview).

![Protein phosphatase type 1 (PP1) is required for the ubiquitination of Pma1 in the Pma1 endocytic downregulation pathway in yeast lacking a functional V-ATPase; the PP1 catalytic subunit *glc7-12^ts^* single mutant and the *glc7-12^ts^vma2*Δ double mutant cells are grown to the log phase at the permissive temperature of 25°, and then they are shifted to the nonpermissive temperature of 37° for 2 hr. The Pma1 is immunoprecipitated from the shown mutants as described in the *Materials and Methods*. The immunoprecipitates were probed with either anti-Pma1 antibody to observe the total Pma1 using western blotting or anti-ubiquitin antibody to observe the ubiquitinated portion of the Pma1. The amount of Pma1 ubiquitinated in each cell type is expressed as the ratio of the ubiquitinated portion of the Pma1 to that of the total Pma1. The intensity of the Pma1 bands was measured using National Institutes of Health Image J. The representative of three different experiments is shown. wt, wild-type.](655fig3){#fig3}

Endocytic downregulation of Pma1 requires CN {#s12}
--------------------------------------------

CN is a highly conserved, Ser/Thr protein phosphatase activated by Ca^2+^/calmodulin binding. In yeast, stresses such as high concentrations of certain ions, high external pH, high temperature, and high osmolarity result in elevation of cytosolic \[Ca^2+^\], activating CN ([@bib59]; [@bib3]; [@bib9]; [@bib1]; [@bib72]; [@bib22]). Yeast CN is a heterodimer with the catalytic subunit encoded by either of the redundant *[CNA1](http://www.yeastgenome.org/locus/S000004425/overview)* and *[CNA2](http://www.yeastgenome.org/locus/S000004521/overview)* genes, and the regulatory subunit encoded by the *[CNB1](http://www.yeastgenome.org/locus/S000001673/overview)* gene. Both subunits are required for CN function. CN exerts its effects primarily through the activation of the transcription factor [Crz1](http://www.yeastgenome.org/locus/S000004972/overview). Under normal conditions, [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) is phosphorylated and inactive in the cytosol. However, when dephosphorylated by CN, it translocates into the nucleus, binds to DNA, and modulates transcription ([@bib79]; [@bib8]).

Although wild-type yeast cells do not require CN for growth under normal conditions, CN has been reported to be essential in *vma* mutants ([@bib16]; [@bib60]; [@bib81]). The *vma* mutants have higher basal cytosolic \[Ca^2+^\] because the vacuolar H^+^/Ca^2+^ exchanger [Vcx1](http://www.yeastgenome.org/locus/S000002286/overview) cannot operate efficiently in the absence of the vacuolar H^+^ gradient ([@bib53]; [@bib15]). Although defective Ca^2+^ homeostasis could account in part for the synthetic lethality of *vma* and CN mutations, we hypothesized that CN might also be required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants. Interestingly, CN was also reported to control [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity ([@bib24]), and CN regulates endocytosis of some PM transporters by directly modulating the activity of α-arrestins independent of the transcription factor [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) ([@bib52]; [@bib1], [@bib2]).

To assess whether CN has a role in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytic downregulation, we made a *[CNB1](http://www.yeastgenome.org/locus/S000001673/overview)* and V-ATPase double mutant, *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ, through tetrad dissection. Although deletion of CN in *vma* mutants was reported to be synthetically lethal ([@bib16]), we observed extremely poor growing *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutants at low temperature on YPD pH 5 plates ([Figure 4A](#fig4){ref-type="fig"}). In [Figure 4, B and C](#fig4){ref-type="fig"}, we determined the localization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in each of the four spores of one of the tetrads in [Figure 4A](#fig4){ref-type="fig"}. In the *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ mutant that lacks CN activity, [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localizes at the PM similarly to the wild-type cells. As expected, the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells constitutively internalize a portion of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview). In contrast, the *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double-mutant cells retained [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM. To confirm the requirement of CN for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization, we treated *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells, with the CN-specific inhibitor FK506 ([@bib7]) for 2, 4, and 6 hr ([Figure 4, D and E](#fig4){ref-type="fig"}), and checked the localization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at each time point. After 2 hr of FK506 treatment, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells still had a substantial amount of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) inside the vacuole, but had more [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM than the vehicle (DMSO)-treated control. At 4 hr, PM localization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) was increased, and by 6 hr of FK506 treatment [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) was entirely at the PM. This result shows that inhibiting CN inhibits [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants, consistent with the *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double-mutant phenotype in [Figure 4, B and C](#fig4){ref-type="fig"}.

![Calcineurin is required for the internalization of Pma1 in the yeast cells lacking functional V-ATPases. (A) Two tetrads obtained from the cross of a calcineurin mutant, BY 4742 *cnb1*Δ::*nat*, with a *vma* mutant, BY 4741*vma2*Δ::*kan*. The *cnb1*Δ*vma2*Δ double mutant grows very poorly compared to the single mutants. (B) Anti-Pma1 indirect immunofluorescence from the spores in a tetrad shown in (A). The cells were allowed to grow in YEP dextrose medium pH 5 to the log phase, and were then fixed as described in the *Materials and Methods* to monitor the localization of Pma1. (C) Bar graph showing the plasma membrane Pma1 fluorescence intensity as a fraction of total cell fluorescence intensity (arbitrary units) in different cells in (B). From each strain, 52 cells were quantified for the fluorescent intensity of Pma1 at the plasma membrane as a measure of the amount of Pma1 retaining at the plasma membrane, as described in the *Materials and Methods*. The *P*-value ≤ 0.05 was considered significant. In the bar graph, \*\*\* *P* \< 0.0005. *P* \> 0.05 was considered nonsignificant and nonsignificant differences were not indicated in the bar graph. The error bars indicate ± SEM. (D) The *vma2*Δ cells were treated with either DMSO or with 10 μg/ml of a calcineurin inhibitor, FK506. The cells were collected 2, 4, and 6 hr after treatment and fixed to observe the Pma1 localization using anti-Pma1 indirect immunofluorescence. In the DMSO-treated cells, only the 6 hr time point is shown. A representative of three different experiments is shown. (E) Bar graph showing the plasma membrane Pma1 fluorescence intensity as a fraction of total cell fluorescence intensity (arbitrary units) from cells in (D). From each condition, 52 cells were quantified for the fluorescent intensity of Pma1 at the plasma membrane as a measure of the amount of Pma1 retaining at the plasma membrane, as described in the *Materials and Methods*. The *P*-value ≤ 0.05 was considered significant. In the bar graph, \*\*\* *P* \< 0.0005. *P* \> 0.05 was considered nonsignificant and nonsignificant differences are not indicated in the bar graph. The error bars indicate ± SEM. (F) Micrograph showing the uptake of FM 4-64 dye in *vma2*Δ cells treated with either DMSO or the calcineurin inhibitor FK506. Cells were initially labeled on ice to mark only the plasma membranes and immediately imaged using a Texas Red filter. Later, cells were chased at 30° for 2, 4, and 6 hr in the presence of either DMSO or the calcineurin inhibitor FK506, as described in the *Materials and Methods*, and imaged using a Texas Red filter to monitor the uptake of FM 4-64 from the plasma membrane to the vacuole. wt, wild-type.](655fig4){#fig4}

CN's inhibitory effect on [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization could be due to the inhibition of bulk endocytosis from the PM. As with [PP1](http://www.yeastgenome.org/locus/S000000935/overview), we assayed the uptake of FM 4-64 dye in *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells treated with FK506 ([Figure 4F](#fig4){ref-type="fig"}). As in [Figure 2](#fig2){ref-type="fig"}, *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells pulse labeled on ice with FM 4-64 exhibited only PM fluorescence, but when chased at 30° for 2, 4, and 6 hr in the presence of FK506 the FM 4-64 internalized and labeled vacuolar membranes, indicating that CN inhibition does not inhibit endocytosis. These results show that CN is required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants.

CN could be driving the internalization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) by modulating transcription through the activation of the CN-dependent transcription factor [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) or directly targeting some critical component in the pathway. We examined the localization of [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) tagged with GFP in wild-type and *vma* mutant cells. Inactive [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) is a cytosolic protein, and in wild-type cells [Crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP localizes diffusely in the cytosol ([Figure 5A](#fig5){ref-type="fig"}). However, in 30% of *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells, [Crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP is concentrated in the nucleus (only 7% of wild-type cells have nuclear [Crz1](http://www.yeastgenome.org/locus/S000004972/overview)-GFP). This provides further support for constitutive CN activation in *vma* mutants and suggests that CN-dependent transcription could affect [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization. If this were true, we would predict that *vma* mutants require the [Crz1](http://www.yeastgenome.org/locus/S000004972/overview) protein for normal growth. We made the *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutant through tetrad dissection and compared its growth with corresponding single mutants using a dilution growth assay ([Figure 5B](#fig5){ref-type="fig"}). The *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*Δ single mutant has no growth defects under the conditions checked, and the *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*Δ*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ double mutant grows comparably to the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ mutant, in contrast to the severe growth defect of the *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*∆*[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutant. In *[crz1](http://www.yeastgenome.org/locus/S000004972/overview)*∆ *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ double mutants, [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization was similar to that in *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells ([Figure 5, C and D](#fig5){ref-type="fig"}). This result indicates that in the absence of V-ATPase activity, CN is driving [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization not by modulating transcription through [Crz1](http://www.yeastgenome.org/locus/S000004972/overview), but by directly acting on another critical component in the pathway.

![Endocytic downregulation of the Pma1 in the yeast lacking a functional V-ATPase is independent of the calcineurin-dependent transcription factor Crz1. (A) Calcineurin-dependent transcription factor Crz1 is tagged with GFP in wild-type (wt) and *vma2*Δ cells, and the localization of Crz1-GFP is monitored using a fluorescent microscope. To identify the nucleus, the cells were stained with DAPI. (B) Dilution growth assay comparing the growth of the *crz1*Δ*vma2*Δ double mutant with the corresponding single mutants. The *crz1*Δ*vma2*Δ double mutant is made as described in the *Materials and Methods*. (C) Anti-Pma1 indirect immunofluorescence image comparing the localization of Pma1 in the *crz1*Δ*vma2*Δ double mutant with the corresponding single mutants and wt cells. The cells were fixed for immunofluorescence as described in the *Materials and Methods*. A representative from three independent experiments is shown. (D) Bar graph showing the plasma membrane Pma1 fluorescence intensity as a fraction of total cell fluorescence intensity (arbitrary units) from cells in (C). From each strain, 52 cells were quantified for the fluorescence intensity of Pma1 at the plasma membrane as a measure of the amount of Pma1 retaining at the plasma membrane, as described in the *Materials and Methods*. The *P*-value ≤ 0.05 is considered significant. In the bar graph, \*\*\* *P* \< 0.0005. *P* \> 0.05 is considered nonsignificant and nonsignificant differences are not indicated in the bar graph. The error bars indicate ± SEM. wt, wild-type.](655fig5){#fig5}

CN acts upstream of Rim8/Rsp5-dependent ubiquitination of Pma1 {#s13}
--------------------------------------------------------------

To further probe the role of CN in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization, we examined the effect of loss of CN activity on [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination. We immunoprecipitated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) from wild-type cells, and from *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells treated with either DMSO or the CN inhibitor FK506, for 2, 4, and 6 hr ([Figure 6](#fig6){ref-type="fig"}). Immunoprecipitated proteins were probed with anti-[Pma1](http://www.yeastgenome.org/locus/S000002976/overview) and anti-ubiquitin antibodies as described above. The wild-type cells had no ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) and the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells, untreated or treated with DMSO, contain ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview). However, after 4 and 6 hr of FK506 treatment, the level of ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) had declined, as had the ratio of the ubiquitin signal to the total [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) signal. This is consistent with the retention of PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at these time points in [Figure 4, D and E](#fig4){ref-type="fig"}. Although the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ cells treated with FK506 for 2 hr appeared to have more [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM than the DMSO-treated cells in [Figure 4, D and E](#fig4){ref-type="fig"}, the level of ubiquitinated [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) was similar to that of the DMSO-treated *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ χελλσ. These results suggest that CN acts upstream of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination and endocytosis in the *vma* mutants.

![Calcineurin is required for the ubiquitination of Pma1 in the Pma1 endocytic downregulation pathway in the yeast lacking functional V-ATPases. The V-ATPase mutant *vma2*Δ cells were treated with either DMSO for 6 hr or with the calcineurin inhibitor FK506 for 2, 4, and 6 hr, then the Pma1 was immunoprecipitated from these cells, as described in the *Materials and Methods*. The immunoprecipitates were probed with either anti-Pma1 antibody to observe the total Pma1 using western blotting or anti-ubiquitin (Ub) antibody to observe the ubiquitinated portion of the Pma1. The amount of Pma1 ubiquitinated in each sample is expressed as the ratio of the ubiquitinated portion of the Pma1 to that of the total Pma1. The Intensity of the Pma1 bands was measured using National Institutes of Health Image J. A representative from three independent experiments is shown. IP, immunoprecipitation; wt, wild-type.](655fig6){#fig6}

Does reduced PM Pma1 compensate for loss of V-ATPase activity? {#s14}
--------------------------------------------------------------

Yeast cells cannot survive without [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity, but yeast *vma* mutants have roughly half the level of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) protein and activity in the PM ([@bib42]; [@bib71]; [@bib67]). As shown above and in previous work, mutations that block internalization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) cause severe synthetic growth phenotypes when combined with *vma* mutations. These results indicate that if *vma* mutants endocytose all the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) they will die, and if they do not internalize some of the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) they will still die. The intriguing question is how the *vma* mutants are tackling this challenge. In other words, how do they sense the level of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization that provides the maximum growth advantage?

The *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* strain has a small deletion in the *[PMA1](http://www.yeastgenome.org/locus/S000002976/overview)* promoter region and, as a result, expresses only ∼50% of the wild-type [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) level ([@bib57]). Because this represents a reduction in PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) that is very similar to the reduction seen in [vma2](http://www.yeastgenome.org/locus/S000000331/overview)∆ mutants ([@bib67]; and [Figure 1C](#fig1){ref-type="fig"}, [Figure 2D](#fig2){ref-type="fig"}, [Figure 4E](#fig4){ref-type="fig"}, and [Figure 5C](#fig5){ref-type="fig"}), we hypothesized that *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutation might rescue growth of the *vma* mutants without the need for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis. No double-mutant spores were obtained after sporulation of a diploid heterozygous for the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ and *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutations, indicating that *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ and *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutations may be synthetically lethal ([Figure 7A](#fig7){ref-type="fig"}). To investigate the source of the synthetic lethality, we treated the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutant with the V-ATPase inhibitor concanamycin A and observed [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization ([Figure 7B](#fig7){ref-type="fig"}). The untreated *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutant has lower levels of PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), as expected. After 30 min of concanamycin A treatment, both wild-type and *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* cells contain internal puncta corresponding to internalized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview). This result indicates that inhibition of the V-ATPase in *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* cells triggers the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization despite already reduced levels of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) on the PM. Therefore, it appears that *vma* mutants cannot sense the amount of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM and continue to signal for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) downregulation, likely resulting in too little PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity to support viability.

![Yeast cells lacking functional V-ATPases continue to signal the downregulation of Pma1 through endocytosis, even when the Pma1 expression is reduced by half. (A) The tetrads obtained by crossing the *Pma1-007* strain, which expresses 50% less Pma1, with the *vma2*Δ cells to isolate the *pma1-007vma2*Δ double mutant through tetrad dissection. In the tetrads obtained, double-mutant spores failed to grow. (B) Anti-Pma1 indirect immunofluorescence image showing the localization of Pma1 in the wild-type (wt), *pma1-007*, and *rcy1*∆ cells either untreated or treated with 2 μM of the V-ATPase inhibitor concanamycin A. (C) Dilution growth assay comparing the growth of triple mutant *vma2*∆ *rim8P506A Pma1007* with the corresponding single and double mutants. The triple and double mutants in this figure are made as described in the *Materials and Methods*.](655fig7){#fig7}

We hypothesized that the prevention of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007vma2*Δ double mutant by deleting *[RIM8](http://www.yeastgenome.org/locus/S000003013/overview)* might rescue growth. We crossed a *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆*[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*∆ mutant carrying wild-type *[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)* on a pRS316 (CEN, *URA*) plasmid (pRS316-*[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)*) with the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutant, then sporulated the resulting diploid. We obtained triple mutant *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*Δ *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* spores carrying the *[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)* plasmid. However, when we tried to evict the plasmid on plates containing 5-FOA, the triple mutants did not grow (data not shown). Because a *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*∆ mutant might have pleiotropic effects, we also used a [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) PY motif mutant, which cannot bind to the [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) ubiquitin ligase. We generated a *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *rim8P506A-3HA [pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* triple mutant spore bearing pRS316-*[VMA2](http://www.yeastgenome.org/locus/S000000331/overview)*. As shown in [Figure 7C](#fig7){ref-type="fig"}, the triple mutant cannot evict the plasmid and grow on 5-FOA medium, indicating that blocking [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis did not rescue growth of the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*Δ *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* triple mutant. The double mutant *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *rim8P506A-3HA* grew very poorly, like the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆*[rim8](http://www.yeastgenome.org/locus/S000003013/overview)*∆ mutant ([Figure 1A](#fig1){ref-type="fig"}). Double mutant *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*Δ *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* also failed to grow on 5-FOA plates, corroborating the result in [Figure 7A](#fig7){ref-type="fig"}. Taken together, these results indicate that simple downregulation of PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity may not fully account for the compensatory effects of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization in *vma* mutants. Instead, it may also be important to populate endosomal compartments with [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), before its final delivery and degradation within the vacuole.

If this is the case, we might expect that when V-ATPase activity is lost, internalized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) gains access to internal compartments that it does not generally occupy. To begin to address this, we examined [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) localization in an *[rcy1](http://www.yeastgenome.org/locus/S000003740/overview)*∆ mutant, which blocks PM proteins in an early endosome after endocytosis ([@bib75]), and also traps several transporters that constitutively cycle through early endosomes and back to the PM ([@bib37]). As described previously ([@bib75]), [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) does not recycle and thus remains completely at the PM in an *[rcy1](http://www.yeastgenome.org/locus/S000003740/overview)*∆ mutant. However, after a 30 min treatment with concanamycin A, [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is observed in puncta in the *[rcy1](http://www.yeastgenome.org/locus/S000003740/overview)*∆ mutant that are very similar to those seen in wild-type cells in [Figure 7C](#fig7){ref-type="fig"}. This suggests that internalized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) reaches early endosomes, and could potentially contribute to their acidification, although we cannot directly measure endosomal pH at present.

Discussion {#s15}
==========

A scheme for ubiquitination and endocytosis of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is shown in [Figure 8](#fig8){ref-type="fig"}. Consistent with models developed for other α-arrestins ([@bib34]; [@bib23]; [@bib5]; [@bib30]), we envision [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) as detecting a loss of V-ATPase activity and acting as an adaptor to bring [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) to the PM, where it ubiquitinates a subpopulation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) at the PM, targeting this population for endocytosis and degradation. In this work, we add two new players to this pathway, conserved protein phosphatases CN and [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview), and provide further evidence that endocytosis of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is essential when organelle acidification is compromised, suggesting that it represents a critical compensatory pathway required for rebalancing pH homeostasis. Finally, we present evidence that endocytosis of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) may play a role beyond partial clearance of the proton pump from the membrane to downregulate its activity.

![Schematic showing a working model for Pma1 downregulation in yeast lacking functional V-ATPases. Lack of V-ATPases at acidic organelles such as vacuoles and endosomes results in increased organelle pH and decreased cytosolic pH. Moreover, lack of V-ATPase signals ubiquitination of ∼50% of Pma1 at the plasma membrane by E3-Ubiquitin ligase Rsp5, aided by the PY motif containing α-arrestin Rim8, leading to the internalization of Pma1 through endocytosis to finally degrade in the vacuolar lumen. Two phosphatases Glc7 (PP1) and calcineurin (CN) are required for the ubiquitination and downregulation of Pma1 through endocytosis. While the targets of these phosphatases are yet to be determined, the schematic shows potential targets of the phosphatases in dotted arrows with question marks. cmd, calmodulin.](655fig8){#fig8}

How cells recognize loss of V-ATPase activity and signal this loss to [Rim8](http://www.yeastgenome.org/locus/S000003013/overview), and ultimately to [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), is an important question. Loss of balance between V-ATPase and [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity has been invoked as a factor in yeast replicative aging ([@bib25]), and the significance of intercompartmental contributions to overall pH balance is highlighted by recent work ([@bib21]). This pH-balancing act between compartments can occur on both short and long timescales. Although *vma* mutants experience a chronic loss of V-ATPase activity, we have previously demonstrated that V-ATPase inhibition with concanamycin A elicits ubiquitination and endocytosis of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) in \< 30 min ([@bib67]). This suggests that the response can be rapid, consistent with that observed in other pathways involving α-arrestins ([@bib23]; [@bib5]), as well as constitutive in the *vma* mutants. The experiments described have eliminated some candidate pathways for cross talk between organellar V-ATPases and PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), while suggesting other pathways. Specifically, although [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) plays an essential role in [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination and endocytosis, it appears to act independently of the RIM ambient pH response pathway, since neither upstream sensor [Rim21](http://www.yeastgenome.org/locus/S000005238/overview) nor downstream effector [Rim20](http://www.yeastgenome.org/locus/S000005801/overview) of the RIM pathway ([@bib56]; [@bib40]) are required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis. This result suggests that [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) is "moonlighting" in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytic pathway. The early steps in the RIM pathway are geared toward sensing extracellular pH ([@bib56]), but in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathway it is likely that [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) detects changes in organelle or cytosolic pH directly or indirectly. We have not eliminated the possibility that [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) is a direct pH sensor, but the requirements for protein phosphatases CN and [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytic pathway suggest other possible mechanisms through which cells might recognize a loss of V-ATPase activity.

The requirement for CN suggests that elevated cytosolic Ca^2+^ might help signal a loss of V-ATPase activity. We previously measured cytosolic Ca^2+^ responses in the *vma* mutants and in the presence of concanamycin A ([@bib15]). In fungi, the vacuole is a major Ca^2+^ store, and one of the most important uptake mechanisms is a Ca^2+^/H^+^ exchanger that exploits the V-ATPase-generated proton gradient ([@bib47]). However, CN is involved in recognizing other stresses as well, ranging from high salt to pH stress ([@bib9]), so we cannot assume that elevated cytosolic Ca^2+^ alone serves as a surrogate signal for loss of vacuolar acidification. Interestingly, CN control of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity has been described previously ([@bib77]). Expression of a constitutively active form of CN in wild-type cells decreased [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity ([@bib77]). Plants lack CN, but plant [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity was decreased when a constitutively active form of yeast CN was heterologously expressed in tomato ([@bib41]). In these settings, localization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) was not determined, but the results are consistent with CN downregulating [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity. In contrast, the requirement for [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) evokes the well-established links between glucose availability and pH sensing ([@bib20]; [@bib10]). The [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) complex is involved in recovery from starvation and is the major phosphatase involved in downregulating [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) activity ([@bib73]). We have shown that [Snf1](http://www.yeastgenome.org/locus/S000002885/overview) activity is similar between wild-type and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ cells ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.117.300594/-/DC1/FigureS2.tiff)). However, [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) has also been associated with pH control. Specifically, [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity and cytosolic pH are higher in a *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*∆ mutant under glucose-limited conditions ([@bib80]), suggesting that the mutant fails to adjust [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) activity during glucose deprivation and consistent with a role for [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) in [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) downregulation. Glucose deprivation lowers the cytosolic pH and raises the vacuolar pH, mimicking the conditions in *vma* mutants, where vacuolar pH is higher and cytosolic pH is lower even in the presence of glucose ([@bib42]; [@bib71]). It is possible that loss of V-ATPase activity could transmit a signal similar to glucose deprivation via cytosolic pH changes.

Placement of CN and [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) activity in the scheme for [Rim8](http://www.yeastgenome.org/locus/S000003013/overview)-mediated signaling of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis ([Figure 8](#fig8){ref-type="fig"}) is difficult because the targets of these phosphatases remain unclear. We demonstrate here that [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) and CN are required for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination in response to loss of V-ATPase activity ([Figure 3](#fig3){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"}), placing them upstream of the [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview)-mediated ubiquitination step in [Figure 8](#fig8){ref-type="fig"}. The α-arrestins themselves are often highly phosphorylated proteins that, in some cases, are also ubiquitinated by [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) ([@bib34]; [@bib38]; [@bib46]; [@bib27]; [@bib30]). Phosphorylation patterns on the α-arrestins change in response to signals for transporter downregulation, and their activation often requires dephosphorylation. For example, CN-mediated dephosphorylation of α-arrestin [Aly1](http://www.yeastgenome.org/locus/S000001729/overview)/[Art6](http://www.yeastgenome.org/locus/S000001729/overview) at certain sites triggers its ability to promote ubiquitination and downregulation of the [Dip5](http://www.yeastgenome.org/locus/S000006186/overview) acidic amino acid transporter ([@bib52]). Similarly, glucose promotes dephosphorylation of α-arrestin [Rod1](http://www.yeastgenome.org/locus/S000005544/overview)/[Art4](http://www.yeastgenome.org/locus/S000005544/overview), releasing [Art4](http://www.yeastgenome.org/locus/S000005544/overview) to interact with [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview) and promote the ubiquitination and endocytosis of hexose transporters at the PM ([@bib5]; [@bib30]). [@bib28] identified multiple casein kinase phosphorylation sites in the hinge region of the N-terminal arrestin domain of [Rim8](http://www.yeastgenome.org/locus/S000003013/overview), and investigated the role of these sites in the RIM pathway. Interestingly, they found that the dephosphorylated [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) was constitutively active in RIM pathway signaling, but that the phosphorylation itself appeared to be independent of extracellular pH. [@bib28] have reported that [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) presents as three to four distinct bands that represent different phosphorylated and ubiquitinated species, but the exact distribution of phosphorylated forms in each band has not been elucidated. We have visualized [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) in wild-type and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutants, but we see little difference in their electrophoretic mobility by SDS-PAGE (data not shown). Further experiments will be necessary to dissect the exact phosphorylation sites on [Rim8](http://www.yeastgenome.org/locus/S000003013/overview) under different conditions, their relevance to the RIM and [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization pathways, and their susceptibility to CN- and/or [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)-mediated dephosphorylation.

One difference between [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis and other α-arrestin-mediated pathways of permease internalization is that the extent of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis must be tightly regulated to retain sufficient PM [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) for viability. Highlighting the importance of this balance, the synthetic lethality of the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* and *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutations ([Figure 7](#fig7){ref-type="fig"}) may arise from further depletion of already reduced [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) levels at the PM. Given the fact that too much internalization of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) is lethal, it is attractive to propose that a [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) subpopulation is designated, possibly by dephosphorylation, for ubiquitination and endocytosis upon loss of V-ATPase activity. Several sites of phosphorylation have been reported in the cytosolic N- and C-terminal domains of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) that could be targeted by [Glc7](http://www.yeastgenome.org/locus/S000000935/overview)/[Reg1](http://www.yeastgenome.org/locus/S000002435/overview) and/or CN to designate a subpopulation for endocytosis ([@bib20]; [@bib12]; [@bib32]; [@bib43]). [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) reverses Ptk2-generated phosphorylation on S899 of the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) C-terminal tail ([@bib43]), although it is not clear whether [Reg1](http://www.yeastgenome.org/locus/S000002435/overview) is required for this step. [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) phosphorylation on S899 occurs in the presence of glucose and contributes to enzyme activation, while [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) reverses the S899 phosphorylation and activation when glucose is scarce ([@bib43]). If dephosphorylation of S899 were the sole role of [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) in signaling [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) downregulation, then we hypothesized that we might bypass [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) by preventing [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) phosphorylation in a *[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*∆ mutant. However, we saw no suppression of *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12 [vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ growth defects in a *[ptk2](http://www.yeastgenome.org/locus/S000003820/overview)*∆ mutant ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.117.300594/-/DC1/FigureS1.tiff)). This indicates that dephosphorylation of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) S899 by [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) is not the essential role of [Glc7](http://www.yeastgenome.org/locus/S000000935/overview) in generating [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination and endocytosis. However, there are other phosphorylated residues in the [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) C-terminal tail that could still be important in designating a population for ubiquitination and downregulation. Specifically, [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) S911 phosphorylation has been implicated in glucose activation, but neither the kinase responsible, nor the phosphatase responsible for dephosphorylation, has been identified ([@bib32]; [@bib43]). Interestingly, a study that isolated ubiquitinated peptides from the yeast cell proteome and determined whether they were also phosphorylated ([@bib70]) identified the C-terminal K916 as a potential [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ubiquitination site. The highest level of K916 ubiquitination was observed in nonphosphorylated C-terminal peptides, although some K916 ubiquitination was found in combination with phosphorylated S911 and T912 ([@bib70]). Although these experiments were conducted under conditions where the V-ATPase is active, they suggest interdependent patterns of modification that could be enhanced when organelle acidification is lost.

Consistent with our previous data suggesting that [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) internalization is an essential compensatory pathway in *vma* mutants ([@bib67]), we found that the introduction of mutations that block [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis---including *[cnb1](http://www.yeastgenome.org/locus/S000001673/overview)*∆, *[reg1](http://www.yeastgenome.org/locus/S000002435/overview)*∆, and *[glc7](http://www.yeastgenome.org/locus/S000000935/overview)-12*---into the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutant caused severe synthetic negative growth phenotypes. The nature of this compensatory effect is not clear. If the compensatory role of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis were simply to reduce [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) levels at the PM, we anticipated that reducing [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) levels via the promoter mutation *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* would bypass the need for [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) endocytosis. However, the *[pma1](http://www.yeastgenome.org/locus/S000002976/overview)-007* mutation does not suppress the requirement for [Rim8](http://www.yeastgenome.org/locus/S000003013/overview)-mediated endocytosis in the *[vma2](http://www.yeastgenome.org/locus/S000000331/overview)*∆ mutant ([Figure 7](#fig7){ref-type="fig"}). These results indicate that not only do cells fail to actively sense the level of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) protein at the PM, but internal [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) may even help to compensate for loss of V-ATPase activity. Internalized [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) ends up in the vacuolar interior where it is degraded, and there is no increase in the vanadate-sensitive ATPase activity (characteristic of [Pma1](http://www.yeastgenome.org/locus/S000002976/overview)) in vacuoles isolated from *vma* mutant cells ([@bib42]). In addition, there is no acidification of vacuoles in the *vma* mutants upon glucose addition, suggesting that [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) does not contribute to vacuolar acidification ([@bib42]). It is likely that [Pma1](http://www.yeastgenome.org/locus/S000002976/overview), like other membrane proteins destined for vacuolar degradation, enters the interior of the multivesicular body prior to its arrival at the vacuole. However, it is possible that [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) could provide some acidification of early endocytic compartments, such as the early endocytic compartment that accumulates in a *[rcy1](http://www.yeastgenome.org/locus/S000003740/overview)*∆ mutant ([Figure 7C](#fig7){ref-type="fig"}), and that this could help account for the compensatory effect. Another alternative is that the mild cytosolic acidification seen in *vma* mutants passively promotes acidification of organelles such as early endosomes. There are currently no probes available that provide ratiometric pH measurement of yeast endosomes; but, using a ratiometric probe of Golgi pH, we observed that as cytosolic pH decreased in the *vma* mutants, Golgi pH also decreased, despite the lack of functional V-ATPases ([@bib71]). In both of these models, the cell would kill part of the tight cytosolic pH control provided by [Pma1](http://www.yeastgenome.org/locus/S000002976/overview) to partially compensate for the loss of organelle acidification.
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